Pharmacognosy and pharmacobiotechnology /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Kar, Ashutosh
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New Delhi : New Age International (P) Ltd., 2003.
Edición:Rev. -expanded 2nd ed.
Temas:
Pharmacognosy.
Pharmaceutical biotechnology.
Pharmacognosy
Pharmacognosie.
Biotechnologie pharmaceutique.
HEALTH & FITNESS > Herbal Medications.
Pharmaceutical biotechnology
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Cover
  • Preface to the Second Edition
  • Preface to the First Edition
  • Contents
  • Chapter 1. Introduction
  • 1.1 Pharmacognosy-A Brief History
  • 1.2 Importance of Natural Drug Substances
  • 1.2.1 Serve as Extremely Useful Natural Drugs
  • 1.2.2 Provide Basic Compounds Affording Less Toxic and More Effective Drug Molecules
  • 1.2.3 Exploration of Biologicalâ€?Activeâ€?Prototypes towards Newer and Better Synthetic Drugs
  • 1.2.4 Modificaton of Inactive Natural Products by Suitable Biological/Chemical Means into Potent Drugs
  • 1.3 Natural Drugs Substances: Cultivation and Production 1.3.1 Plant Products
  • 1.3.2 Cell-Culture Techniques
  • 1.3.3 Microbial Metabolites
  • 1.3.4 Animal Derivatives
  • 1.4 Phytochemistry
  • 1.4.1 Constituents
  • Chapter 2. Pharmacobiotechnology
  • 2.1 Introduction
  • 2.2 Theory
  • 2.2.1 Mutation, Crossing-over and Recombinant of Meiosis
  • 2.2.2 Third Revolution in Modern Medicine
  • 2.2.3 Genetic Code
  • 2.2.4 Specific Sets of Genes in Each Individual Organ
  • 2.2.5 Reverse Transcriptase (RT)
  • 2.2.6 3D-Proteins
  • 2.2.7 From Nervous System to Immune System2.2.8 Bodyâ€?s Defence Mechanism
  • 2.2.9 PCRâ€?in Forensic & Research
  • 2.2.10 DNAâ€?in Metabolic Pathways
  • 2.2.11 Recombinant Vaccination Vector
  • 2.2.12 OKT3â€?Monoclonal Antibody
  • 2.3 Important Means in Biotechnology
  • 2.3.1 Recombinant DNA (rDNA)
  • 2.3.2 Restriction Enzymes
  • 2.3.3 DNAâ€?Ligase
  • 2.3.4 Cloning Vector
  • 2.3.5 Hybridization Probes
  • 2.3.6 Cloning Process
  • 2.4 Recombinant Proteins
  • 2.4.1 Bacterial Systems
  • 2.4.2 Glycosylation
  • 2.4.3 Mammalian Tissue Culture Expression Systems2.5 Biotechnology Vs Modern Pharmacy Practice
  • 2.5.1 Human Proteins as Drugs
  • 2.5.2 New Drug Classes
  • 2.5.3 Vaccines
  • 2.5.4 New Immunodiagnostic Agents
  • 2.5.5 DNA Probes and RFLP Analysis
  • 2.5.6 Enzyme Linked Immunosorbant Assay (ELISA)
  • 2.6 Biotechnology Based Pharmaceuticlas for the Millennium
  • 2.6.1 Genetically Engineered Vaccine
  • 2.6.2 Gene Splicing and DNA Recombinant Procedures
  • 2.6.3 Antibodies in Biotechnology
  • 2.6.4 Gene Therapy
  • 2.6.5 3D Picture of the â€?Lockâ€? and â€?Keysâ€?
  • 2.7 Biotechnology and Modern Drug Discovery 2.7.1 Approved Medicines
  • 2.7.2 Medicines Under Development
  • 2.7.3 Human Clone
  • 2.8 Biotechnology: Some Thought Provoking Newer Ideas
  • 2.8.1 Potato Vaccine
  • 2.8.2 Functional Food Revolution
  • Chapter 3. Carbobhydrates
  • 3.1 Introductioin
  • 3.2 Classification
  • 3.2.1 Homoglycans
  • 3.2.2 Heteroglycans
  • 3.3 Carbohydrate Biogenesis
  • Chapter 4. Glycosides
  • 4.1 Introduction
  • 4.1.1 O-Glycosides
  • 4.1.2 S-Glycosides
  • 4.1.3 N-Glycosides
  • 4.1.4 C-Glycosides
  • 4.2 Classification

Ejemplares similares